Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action
- PMID: 6202531
- DOI: 10.1016/0014-2999(83)90311-4
Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action
Abstract
Azelastine is a novel, orally effective, long-acting, antiallergic agent. The ability of azelastine to influence calcium ionophore A23187-induced histamine release from rat peritoneal mast cells was investigated and compared with selected antiallergic drugs. The concentrations of drugs required to inhibit A23187 (0.2 microM)-stimulated histamine release by 50% (IC50S, microM) were as follows: azelastine 5; diphenhydramine 52; and ketotifen 200. Theophylline and sodium cromoglycate in a concentration range of 0.1-1000 microM failed to exert any significant inhibition of histamine release. The inhibitory effects of azelastine on A23187-stimulated histamine release were antagonized by high concentrations of exogenous Ca2+ ions. These data suggest that azelastine inhibits A23187-stimulated histamine release by interfering with the influx of Ca2+ into the mast cells.
Similar articles
-
Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs.Agents Actions. 1985 Jul;16(5):318-22. doi: 10.1007/BF01982866. Agents Actions. 1985. PMID: 2413739
-
Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells.J Allergy Clin Immunol. 1984 Mar;73(3):400-3. doi: 10.1016/0091-6749(84)90415-9. J Allergy Clin Immunol. 1984. PMID: 6199399
-
Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes.Int Arch Allergy Appl Immunol. 1985;77(4):451-5. doi: 10.1159/000233825. Int Arch Allergy Appl Immunol. 1985. PMID: 2410374
-
Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.Drugs. 1989 Nov;38(5):778-800. doi: 10.2165/00003495-198938050-00005. Drugs. 1989. PMID: 2574665 Review.
-
Melatonin in mast cells and tumor radiosensitivity.J Pineal Res. 1997 Apr;22(3):169-70. doi: 10.1111/j.1600-079x.1997.tb00319.x. J Pineal Res. 1997. PMID: 9213271 Review. No abstract available.
Cited by
-
Azelastine and allergen transduction signal in MC9 mast cells.Naunyn Schmiedebergs Arch Pharmacol. 1993 Nov;348(5):515-9. doi: 10.1007/BF00173212. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7509459
-
Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.Thorax. 1988 Apr;43(4):306-11. doi: 10.1136/thx.43.4.306. Thorax. 1988. PMID: 2900560 Free PMC article. Clinical Trial.
-
Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs.Agents Actions. 1985 Jul;16(5):318-22. doi: 10.1007/BF01982866. Agents Actions. 1985. PMID: 2413739
-
Inhibition of allergic and non-allergic histamine secretion from rat peritoneal mast cells by calcium antagonists.Br J Pharmacol. 1984 Dec;83(4):899-902. doi: 10.1111/j.1476-5381.1984.tb16529.x. Br J Pharmacol. 1984. PMID: 6083814 Free PMC article.
-
A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.Br J Clin Pharmacol. 1988 Nov;26(5):515-25. doi: 10.1111/j.1365-2125.1988.tb05291.x. Br J Clin Pharmacol. 1988. PMID: 2905153 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous